Federal Trade Commission v. Vyera Pharmaceuticals, LLC

  1. January 23, 2024

    2nd Circ. Backs Shkreli Lifetime Pharma Industry Ban

    The Second Circuit on Tuesday backed a ruling banning former pharmaceutical executive and convicted securities fraudster Martin Shkreli from the drug industry for life, saying a repeat of his past misconduct would be "life-threatening."

  2. December 14, 2023

    Shkreli's Lifetime Pharma Ban Goes Too Far, 2nd Circ. Told

    An attorney for former pharmaceutical executive and convicted securities fraudster Martin Shkreli asked a Second Circuit panel to lift a lifetime industry ban on his client, saying it steps on Shkreli's First Amendment rights and bars him from other, unrelated sectors.

  3. July 20, 2023

    Shkreli Not Aided By Top Court's 'True Threat' Case, AGs Say

    The Federal Trade Commission and a group of state attorneys general told the Second Circuit on Thursday that Martin Shkreli can't cite a U.S. Supreme Court decision defining when speech is a "true threat" to overturn his lifetime pharmaceutical industry ban.

  4. July 13, 2023

    Shkreli Argues 'True Threat' Case Backs Lifting Pharma Ban

    Martin Shkreli has told the Second Circuit his appeal of a lifetime pharmaceutical industry ban is bolstered by the U.S. Supreme Court's recent decision that courts must consider a speaker's intent when deciding what is a "true threat."

  5. April 14, 2023

    Shkreli Keeps Fighting 'Needlessly Crushing' Penalties

    Martin Shkreli pressed the Second Circuit on Thursday to overturn his $64.6 million fine and lifetime pharmaceutical industry ban imposed through a Federal Trade Commission and attorneys general antitrust case, arguing the ban is overbroad and his company should be fined, not him.